Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ibuprofen versus ketorolac for pain control in renal colic
IRCT20231112060025N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Renal colic comparing Intravenous ketorolac with Intravenous ibuprofen (2 arms). Primary endpoints: drug side effects and opioid medication requirement. Started Dec 2023; status: completed.
02
Drugs
ibuprofenketorolac
03
Conditions
Renal colic
Beyond the preview
Go deeper on IRCT20231112060025N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231112060025N1.